New peptide (SEQ ID No: 128) and new peptide combinations in immunotherapy for prevention of ovarian infection and other ccers. （Divisional request 201800124）

摘要

T. The current invention of P oacute; n refers to a P amp; eacute; n refers to a P amp; eacute; Iacute; NAS, amp; Aacute; cidos nuclei and C amp; eacute; Lulas refers to uici amp; oacute; n refers to an M amp; eacute refers to all immunology and amp; eacute refers to props. In particular, current inventions and amp; oacute; n refer to immunity to C amp; Aacute; NCER. The invention; oacute; n also refers to EP amp; Iacute; topos pept amp; Iacute; dics for lymphocytic diseases related to tumors, alone or in combination; oacute; N and other P amp; eacute; baptisms are related to tumors, for example,They can be used as effective tools for initial asset 5 pharmacies and amp; eacute; VAC amp compounds; uacute; to stimulate anti-tumor immune response or stimulate pre living lymphocyte T, and the latter, eacute; s ser amp; Aacute; is referred to patients. Lo5 P amp; eacute; impregnation combined with mol amp; eacute; butt of MHC complex,O P eacute; ptidos, tambi eacute; n can be antibody targets, soluble lymphocyte receptors and other mol eacute; uni amp; butt; oacute; n / P